- Home
- LYFT vs CRL Comparison
LYFT vs CRL Comparison
Compare LYFT & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYFT
- CRL
- Stock Information
- Founded
- LYFT 2007
- CRL 1947
- Country
- LYFT United States
- CRL United States
- Employees
- LYFT N/A
- CRL N/A
- Industry
- LYFT Business Services
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LYFT Consumer Discretionary
- CRL Health Care
- Exchange
- LYFT Nasdaq
- CRL Nasdaq
- Market Cap
- LYFT 6.7B
- CRL 7.3B
- IPO Year
- LYFT 2019
- CRL 2000
- Fundamental
- Price
- LYFT $16.66
- CRL $163.99
- Analyst Decision
- LYFT Buy
- CRL Buy
- Analyst Count
- LYFT 30
- CRL 14
- Target Price
- LYFT $17.17
- CRL $186.00
- AVG Volume (30 Days)
- LYFT 20.2M
- CRL 787.7K
- Earning Date
- LYFT 11-05-2025
- CRL 11-05-2025
- Dividend Yield
- LYFT N/A
- CRL N/A
- EPS Growth
- LYFT N/A
- CRL N/A
- EPS
- LYFT 0.22
- CRL N/A
- Revenue
- LYFT $6,111,324,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- LYFT $15.12
- CRL N/A
- Revenue Next Year
- LYFT $13.69
- CRL $1.94
- P/E Ratio
- LYFT $75.26
- CRL N/A
- Revenue Growth
- LYFT 19.94
- CRL N/A
- 52 Week Low
- LYFT $9.66
- CRL $91.86
- 52 Week High
- LYFT $19.07
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- LYFT 61.04
- CRL 56.33
- Support Level
- LYFT $16.29
- CRL $157.20
- Resistance Level
- LYFT $18.30
- CRL $165.22
- Average True Range (ATR)
- LYFT 0.79
- CRL 3.97
- MACD
- LYFT 0.07
- CRL 0.38
- Stochastic Oscillator
- LYFT 53.28
- CRL 78.43
About LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.